FR2690847B1 - Compositions a activite agoniste des recepteurs analogues a 5ht1 selective. - Google Patents

Compositions a activite agoniste des recepteurs analogues a 5ht1 selective.

Info

Publication number
FR2690847B1
FR2690847B1 FR9305432A FR9305432A FR2690847B1 FR 2690847 B1 FR2690847 B1 FR 2690847B1 FR 9305432 A FR9305432 A FR 9305432A FR 9305432 A FR9305432 A FR 9305432A FR 2690847 B1 FR2690847 B1 FR 2690847B1
Authority
FR
France
Prior art keywords
pct
selective
compositions
agonist activity
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9305432A
Other languages
English (en)
Other versions
FR2690847A1 (fr
Inventor
Merlet Nadine
Richard Isabelle
Thielemans Isabelle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Glaxo Wellcome SA
Original Assignee
Laboratoires Glaxo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Glaxo SA filed Critical Laboratoires Glaxo SA
Publication of FR2690847A1 publication Critical patent/FR2690847A1/fr
Application granted granted Critical
Publication of FR2690847B1 publication Critical patent/FR2690847B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
FR9305432A 1992-05-07 1993-05-06 Compositions a activite agoniste des recepteurs analogues a 5ht1 selective. Expired - Lifetime FR2690847B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions

Publications (2)

Publication Number Publication Date
FR2690847A1 FR2690847A1 (fr) 1993-11-12
FR2690847B1 true FR2690847B1 (fr) 1995-06-09

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9305432A Expired - Lifetime FR2690847B1 (fr) 1992-05-07 1993-05-06 Compositions a activite agoniste des recepteurs analogues a 5ht1 selective.

Country Status (33)

Country Link
US (1) US5705506A (fr)
EP (1) EP0639072B1 (fr)
JP (1) JPH07506570A (fr)
KR (1) KR100253111B1 (fr)
AT (1) ATE163850T1 (fr)
AU (1) AU670083B2 (fr)
BE (1) BE1007024A5 (fr)
BG (1) BG62120B1 (fr)
BR (1) BR1100108A (fr)
CA (1) CA2135179C (fr)
CH (1) CH685920A5 (fr)
CY (1) CY2039B1 (fr)
CZ (1) CZ283512B6 (fr)
DE (1) DE69317418T2 (fr)
ES (1) ES2113533T3 (fr)
FR (1) FR2690847B1 (fr)
GB (2) GB9209882D0 (fr)
GR (1) GR3026584T3 (fr)
HK (1) HK95697A (fr)
HU (2) HU227338B1 (fr)
IE (1) IE75203B1 (fr)
IL (1) IL105468A (fr)
IT (1) IT1261471B (fr)
NO (1) NO306700B1 (fr)
NZ (1) NZ252132A (fr)
OA (1) OA10109A (fr)
RO (1) RO112993B1 (fr)
RU (1) RU2118527C1 (fr)
SG (1) SG46649A1 (fr)
TW (1) TW231970B (fr)
UA (1) UA37206C2 (fr)
WO (1) WO1993021916A1 (fr)
ZA (1) ZA933178B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997044062A1 (fr) * 1996-05-23 1997-11-27 Alcon Laboratories, Inc. Utilisation d'agonistes de 5-ht1b/1d dans le traitement de douleurs oculaires
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
ATE464900T1 (de) * 1998-03-26 2010-05-15 Astellas Pharma Inc Retardpräparat mit makroliden wie tacrolimus
AU3731400A (en) * 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Methods and compositions useful in inhibiting apoptosis
EP2813144A1 (fr) 2006-10-09 2014-12-17 Charleston Laboratories, Inc. Compositions analgésiques comprenant un antihistaminique
ES2620672T3 (es) 2008-01-09 2017-06-29 Charleston Laboratories, Inc. Comprimidos de doble capa que comprenden oxicodona y prometazina
WO2011006012A1 (fr) 2009-07-08 2011-01-13 Charleston Laboratories Inc. Compositions pharmaceutiques
BR112013009004B1 (pt) 2010-10-15 2022-05-10 Contera Pharma Aps Uso de composição farmacêutica ou kit de partes compreendendo combinações de agonistas dereceptor de serotonina
BR112014025907B1 (pt) 2012-04-18 2023-02-14 Contera Pharma Aps Formulação farmacêutica disponível para administração por via oral adequada para manejo aprimorado de transtornos do movimento
EP3423041A4 (fr) 2016-03-04 2019-09-11 Charleston Laboratories, Inc. Compositions pharmaceutiques
WO2018011181A1 (fr) 2016-07-11 2018-01-18 Contera Pharma Aps Système d'administration pulsatile de médicament pour le traitement de l'akinésie matinale

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
AU550010B2 (en) * 1980-08-12 1986-02-27 Glaxo Group Limited 5-tryptaminoacetamides, carbamates and ureas
GR79215B (fr) * 1982-06-07 1984-10-22 Glaxo Group Ltd
HU196752B (en) * 1983-12-06 1989-01-30 Glaxo Group Ltd Process for production of medical compositions containing indole-derivatives and these compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
GB2168973B (en) * 1984-12-04 1988-02-03 Glaxo Group Ltd Indole derivatives
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
DE3678805D1 (de) * 1985-11-08 1991-05-23 Glaxo Group Ltd Indolderivate.
US4997841A (en) * 1987-08-13 1991-03-05 Glaxo Group Limited Indole derivatives
CA2064815C (fr) * 1990-06-07 1999-11-16 Alan Duncan Robertson Composes heterocycliques therapeutiques

Also Published As

Publication number Publication date
CY2039B1 (en) 1998-04-30
RU2118527C1 (ru) 1998-09-10
GB9209882D0 (en) 1992-06-24
IE930339A1 (en) 1993-11-17
CH685920A5 (fr) 1995-11-15
EP0639072B1 (fr) 1998-03-11
NO944214L (no) 1994-11-07
ES2113533T3 (es) 1998-05-01
AU670083B2 (en) 1996-07-04
HU227338B1 (en) 2011-04-28
ITRM930286A1 (it) 1994-11-06
WO1993021916A1 (fr) 1993-11-11
DE69317418T2 (de) 1998-07-30
SG46649A1 (en) 1998-02-20
CZ283512B6 (cs) 1998-04-15
FR2690847A1 (fr) 1993-11-12
GB2266665B (en) 1996-05-22
KR100253111B1 (en) 2000-07-01
HUT71418A (en) 1995-11-28
OA10109A (en) 1996-12-18
GB9309209D0 (en) 1993-06-16
CA2135179C (fr) 2000-12-05
DE69317418D1 (de) 1998-04-16
GR3026584T3 (en) 1998-07-31
EP0639072A1 (fr) 1995-02-22
US5705506A (en) 1998-01-06
NO306700B1 (no) 1999-12-13
BR1100108A (pt) 1999-12-07
BG99167A (bg) 1995-06-30
NZ252132A (en) 1996-09-25
IL105468A0 (en) 1993-08-18
JPH07506570A (ja) 1995-07-20
TW231970B (fr) 1994-10-11
CZ272394A3 (en) 1995-10-18
UA37206C2 (uk) 2001-05-15
ZA933178B (en) 1994-01-10
IL105468A (en) 1998-09-24
CA2135179A1 (fr) 1993-11-11
NO944214D0 (no) 1994-11-04
IT1261471B (it) 1996-05-23
RO112993B1 (ro) 1998-03-30
AU4064093A (en) 1993-11-29
BG62120B1 (bg) 1999-03-31
IE75203B1 (en) 1997-08-27
GB2266665A (en) 1993-11-10
BE1007024A5 (fr) 1995-02-21
HU211638A9 (en) 1995-12-28
ATE163850T1 (de) 1998-03-15
HK95697A (en) 1997-08-08
ITRM930286A0 (it) 1993-05-06

Similar Documents

Publication Publication Date Title
EA199900932A1 (ru) Фармацевтические композиции, обладающие активностью подавления аппетита
UA27776C2 (uk) Похідні хінуклідину та їх фармацевтично прийнятні солі, що є антагоністами речовини р у ссавців, фармацевтична композиція, що має антагоністичну дію на речовину р у ссавців
DK0641328T3 (da) Broforbundne, azabicykliske derivater som substans P-antagonister
EP0903349A3 (fr) Antagonistes du récepteur CCR-3
BG106142A (en) Glucocorticoid receptor modulators
NO980669D0 (no) Orale raskt-opplöselige blandinger for dopaminagonister
FR2690847B1 (fr) Compositions a activite agoniste des recepteurs analogues a 5ht1 selective.
ATE148989T1 (de) Partielle agonisten der strychnin unempfindlichen glycinmodulierenden stelle des n-methyl-d- aspartat-rezeptor-komplexes als neuropsycho- pharmakologische wirkstoffe
SE9803760D0 (sv) Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
SE9702002D0 (sv) Novel compounds
TNSN98049A1 (fr) Composition pharmaceutique a residence gastrique.
HUP0004900A2 (hu) Mozgászavarok kezelésére szolgáló, hatóanyagként NMDA-receptor antagonista hatású piperidinszármazékokat tartalmazó gyógyszerkészítmények
FI950209A0 (fi) Farmakologisesti aktiiviset alfa-(tertiaarinen-amino-metyyli)-bentseenimetanolijohdannaiset
EE200200302A (et) Küllastumata 14,15-tsüklopropanoandrostaanid, nende valmistamise meetod ja neid ühendeid sisaldavadfarmatseutilised kompositsioonid